Antibody-drug conjugates

TW202626729APending Publication Date: 2026-07-01DAIICHI SANKYO CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114141087
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-09-06
Filing Date: 2019-09-06
Publication Date: 2026-07-01

Application Information

Patent Timeline

06 Sep 2018

Priority

06 Sep 2019

Application

TW114141087

01 Jul 2026

Publication

TW202626729A

IPC: C07K16/28; A61K47/68; A61P35/00; C07H21/00

Inventors: 津田敏史; 田淵俊樹

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The objective of this invention is to develop novel CDN derivatives possessing STING agonist activity, and therapeutic agents and / or methods for treating diseases related to STING agonist activity using these novel CDN derivatives. Furthermore, it aims to develop therapeutic agents and / or methods for treating diseases related to STING agonist activity that can specifically deliver the novel CDN derivative to target cells or organs. The solution of this invention is to provide novel CDN derivatives possessing strong STING agonist activity and antibody-CDN derivative conjugates containing these novel CDN derivatives.

Need to check novelty before this filing date? Find Prior Art